| For: | Onaolapo AY, Onaolapo OJ. Glutamate and depression: Reflecting a deepening knowledge of the gut and brain effects of a ubiquitous molecule. World J Psychiatr 2021; 11(7): 297-315 [PMID: 34327123 DOI: 10.5498/wjp.v11.i7.297] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3206/full/v11/i7/297.htm |
| Number | Citing Articles |
| 1 |
André Ribeiro Buinho, Francisca Ribeirinho Soares, João Paulo Rema. Exploring Therapeutic Potential: A Comprehensive Review of Novel Treatment Targets in Psychotic Depression. Current Treatment Options in Psychiatry 2024; 11(3) doi: 10.1007/s40501-024-00329-6
|
| 2 |
Benjamin F. Gruenbaum, Alexander Zlotnik, Anna Oleshko, Frederic Matalon, Honore N. Shiyntum, Amit Frenkel, Matthew Boyko. The Relationship between Post-Traumatic Stress Disorder Due to Brain Injury and Glutamate Intake: A Systematic Review. Nutrients 2024; 16(6) doi: 10.3390/nu16060901
|
| 3 |
Hai-Ha Nguyen, Jintanaporn Wattanathorn, Wipawee Thukham-Mee, Supaporn Muchimapura, Pongsatorn Paholpak. Development of a Guava Jelly Drink with Potential Antioxidant, Anti-Inflammation, Neurotransmitter, and Gut Microbiota Benefits. Foods 2025; 14(13) doi: 10.3390/foods14132401
|
| 4 |
Douglas F. Watt. The separation distress hypothesis of depression – an update and systematic review. Neuropsychoanalysis 2023; 25(2) doi: 10.1080/15294145.2023.2240340
|
| 5 |
Shih‐Hsien Lin, Po See Chen, Shih‐Ming Huang, Yen Kuang Yang. Glutamate concentrations related to depression and mania symptoms in patients with Graves' disease: A 1H‐magnetic resonance spectroscopy study. The Kaohsiung Journal of Medical Sciences 2024; 40(8) doi: 10.1002/kjm2.12854
|
| 6 |
Xiangyan Zhou, Sixing Wang, Xiaohui Wang, Xinran Chen, Pei Zhou, Kai Ma, Peng Zhang. Mechanisms of the effect of gut microbes on depression through the microbiota-gut-brain axis. Frontiers in Nutrition 2025; 12 doi: 10.3389/fnut.2025.1634548
|
| 7 |
Annisa Citra Herrastri Hertanto, Ancah Caesarina Novi Marchianti, Muhammad Hasan. Hubungan Antara Pola Makan dan Aktivitas Fisik Terhadap Tingkat Depresi di Masa Pandemi Pada Pelajar SMAN 1 Manyar Gresik, Indonesia. Amerta Nutrition 2023; 7(2) doi: 10.20473/amnt.v7i2.2023.283-294
|
| 8 |
Sebastian Reyes-Lizaola, Ulises Luna-Zarate, Hiram Tendilla-Beltrán, Julio César Morales-Medina, Gonzalo Flores. Structural and biochemical alterations in dendritic spines as key mechanisms for severe mental illnesses. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2024; 129 doi: 10.1016/j.pnpbp.2023.110876
|
| 9 |
Stephanie S. Römer, Theresa A. Larkin, Vida Bliokas, Asmahan Elgellaie, Susan J. Thomas. The association of plasma glutamate with food addiction in individuals with major depressive disorder. Appetite 2026; 216 doi: 10.1016/j.appet.2025.108317
|
| 10 |
Samantha Schildroth, Birgit Claus Henn, Anissa I. Vines, Ruth J. Geller, Sharonda M. Lovett, Chad M. Coleman, Traci N. Bethea, Julianne Cook Botelho, Antonia M. Calafat, Chad Milando, Donna D. Baird, Ganesa Wegienka, Lauren A. Wise. Per- and polyfluoroalkyl substances (PFAS), perceived stress, and depressive symptoms in a prospective cohort study of black women. Science of The Total Environment 2024; 929 doi: 10.1016/j.scitotenv.2024.172445
|
| 11 |
Sepideh Hajivalizadeh, Kimia Farahmand, Kimia Kazemzadeh, Ghazaleh Hajivalizadeh, Ahmad Shamabadi. Pharmacotherapeutic Management of Depression in Patients With Cancer: A Review of Mechanistic and Clinical Evidence. Cancer Reports 2026; 9(5) doi: 10.1002/cnr2.70587
|
| 12 |
Anil Kumar Rana, Babita Bhatt, Chitralekha Gusain, Surya Narayan Biswal, Debashree Das, Mohit Kumar. Neuroimmunometabolism: how metabolism orchestrates immune response in healthy and diseased brain. American Journal of Physiology-Endocrinology and Metabolism 2025; 328(2) doi: 10.1152/ajpendo.00331.2024
|
| 13 |
Hua Fu, Yang Liu. Complex gut–brain interactions underlying inflammatory bowel disease-related depression have translational implications in regenerative medicine: a narrative review. Regenerative Medicine Reports 2024; 1(1) doi: 10.4103/REGENMED.REGENMED-D-24-00006
|
| 14 |
Amy A. Maury, Kathleen F. Holton. Biomarkers Associated with Depression Improvement in Veterans with Gulf War Illness Using the Low-Glutamate Diet. Nutrients 2024; 16(14) doi: 10.3390/nu16142255
|
| 15 |
Aleksandra Szopa, Karolina Bogatko, Anna Serefko, Mariola Herbet, Marta Ostrowska-Leśko, Andrzej Wróbel, Maria Radziwoń-Zaleska, Jarosław Dudka, Piotr Wlaź, Ewa Poleszak. Antidepressant effects of selective adenosine receptor antagonists targeting the A1 and A2A receptors administered jointly with NMDA receptor ligands: behavioral, biochemical and molecular investigations in mice. Pharmacological Reports 2024; 76(5) doi: 10.1007/s43440-024-00627-z
|
| 16 |
Huakang Li, Jing Wang, Yuanzhen Mi, Cuicui Gong, Ziliang Wu, Pengxuan Gu, Wenxi Zhou, Bing Lin, Ke Xu, Jinyi Lang. Causal effects of gut microbiota and blood metabolites on subtypes of perinatal depression classified based on depressive symptom trajectories: a mendelian randomization study. Nutrition & Metabolism 2026; 23(1) doi: 10.1186/s12986-026-01111-6
|
| 17 |
Zahra Bashir, Luisa W. Hugerth, Maria Christine Krog, Stefanie Prast-Nielsen, Gabriella Edfeldt, Fredrik Boulund, Simon Rønnow Schacht, Inge Tetens, Lars Engstrand, Ina Schuppe-Koistinen, Emma Fransson, Henriette Svarre Nielsen. Investigations of microbiota composition and neuroactive pathways in association with symptoms of stress and depression in a cohort of healthy women. Frontiers in Cellular and Infection Microbiology 2024; 14 doi: 10.3389/fcimb.2024.1324794
|
| 18 |
Adejoke Y. Onaolapo, Folusho O. Ojo, Anthony T. Olofinnade, Joshua Falade, Ismail A. Lawal, Olakunle J. Onaolapo. Microbiome-Based Therapies in Parkinson’s Disease: Can Tuning the
Microbiota Become a Viable Therapeutic Strategy?. CNS & Neurological Disorders - Drug Targets 2023; 22(9) doi: 10.2174/1871527321666220903114559
|
| 19 |
Yali Weng, Yu Zhang, Yinhan Li, Xinpei Lin, Zhenkun Guo, Hong Hu, Wenya Shao, Guangxia Yu, Fuli Zheng, Ping Cai, Huangyuan Li, Siying Wu. Single-cell RNA-sequencing of cellular heterogeneity and pathogenic mechanisms in paraquat-induced Parkinson's disease with depression. Ecotoxicology and Environmental Safety 2024; 273 doi: 10.1016/j.ecoenv.2024.116169
|
| 20 |
Lenin Pavón, Danelia Mendieta-Cabrera, Gilberto Pérez-Sánchez, Luis Enrique Becerril-Villanueva, Samantha Alvarez-Herrera, Luis Vallejo-Castillo, Lissette Haydee García-Mena, José Luis Maldonado-García. PsychoNeuroImmunology. Integrated Science 2024; 31 doi: 10.1007/978-3-031-72079-6_6
|
| 21 |
Dania Akbar, Taeho Greg Rhee, Felicia Ceban, Roger Ho, Kayla M. Teopiz, Bing Cao, Mehala Subramaniapillai, Angela T. H. Kwan, Joshua D. Rosenblat, Roger S. McIntyre. Dextromethorphan-Bupropion for the Treatment of Depression: A Systematic Review of Efficacy and Safety in Clinical Trials. CNS Drugs 2023; 37(10) doi: 10.1007/s40263-023-01032-5
|
| 22 |
José Luis Maldonado-García, Lissette Haydee García-Mena, Danelia Mendieta-Cabrera, Gilberto Pérez-Sánchez, Enrique Becerril-Villanueva, Samantha Alvarez-Herrera, Toni Homberg, Luis Vallejo-Castillo, Sonia Mayra Pérez-Tapia, Martha C. Moreno-Lafont, Daniel Ortuño-Sahagún, Lenin Pavón. Use of Extracellular Monomeric Ubiquitin as a Therapeutic Option for Major Depressive Disorder. Pharmaceuticals 2024; 17(7) doi: 10.3390/ph17070841
|
| 23 |
Yara S. Abdelkawy, Mona Elharoun, Eman Sheta, Ihab Talat Abdel-Raheem, Hisham A. Nematalla. Liraglutide and Naringenin relieve depressive symptoms in mice by enhancing Neurogenesis and reducing inflammation. European Journal of Pharmacology 2024; 971 doi: 10.1016/j.ejphar.2024.176525
|
| 24 |
O. K. Savushkina, I. S. Boksha, M. A. Omelchenko, E. B. Tereshkina, T. A. Prokhorova, E. A. Vorobyeva, G. Sh. Burbaeva. Correlations between biochemical and clinical parameters in patients at risk for schizophrenia spectrum disorders. Vestnik nevrologii, psihiatrii i nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery) 2023; (3) doi: 10.33920/med-01-2303-06
|
| 25 |
O.K. Savushkina, I.S. Boksha, M.A. Omel’chenko, E.B. Tereshkina, T.A. Prokhorova, E.A. Vorobieva, G.Sh. Burbaeva. Activity of enzymes of glutamate, energy and glutathione metabolism in the first juvenile depression with attenuated symptoms of schizophrenia. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 2022; 122(8) doi: 10.17116/jnevro2022122081136
|
| 26 |
Benjamin F. Gruenbaum, Kiran S. Merchant, Alexander Zlotnik, Matthew Boyko. Gut Microbiome Modulation of Glutamate Dynamics: Implications for Brain Health and Neurotoxicity. Nutrients 2024; 16(24) doi: 10.3390/nu16244405
|
| 27 |
Matthew Boyko, Benjamin F. Gruenbaum, Anna Oleshko, Igor Merzlikin, Alexander Zlotnik. Diet’s Impact on Post-Traumatic Brain Injury Depression: Exploring Neurodegeneration, Chronic Blood–Brain Barrier Destruction, and Glutamate Neurotoxicity Mechanisms. Nutrients 2023; 15(21) doi: 10.3390/nu15214681
|
| 28 |
Mirsol Choi, Xena Wang, Mohit Singh, Jeremy Weleff. Serotonin Syndrome Masquerading as Alcohol Withdrawal: A Case Report. Journal of Addictive Diseases 2026; 44(3) doi: 10.1080/10550887.2025.2545649
|
| 29 |
Benjamin Fredrick Gruenbaum, Alexander Zlotnik, Amit Frenkel, Ilya Fleidervish, Matthew Boyko. Glutamate Efflux across the Blood–Brain Barrier: New Perspectives on the Relationship between Depression and the Glutamatergic System. Metabolites 2022; 12(5) doi: 10.3390/metabo12050459
|
| 30 |
Simona Mattova, Patrik Simko, Elena Colzi, Erika Stammova, Nicol Urbanska, Maria Grigoroiu-Serbanescu, Elisabetta Coppi, Terezia Kiskova-Simkova. ATP and major affective disorders: the involvement of P2X receptors in pathophysiology. Purinergic Signalling 2026; 22(2) doi: 10.1007/s11302-026-10147-5
|
| 31 |
Cyrus Su Hui Ho, Gabrielle Wann Nii Tay, Hai Ning Wee, Jianhong Ching. The Utility of Amino Acid Metabolites in the Diagnosis of Major Depressive Disorder and Correlations with Depression Severity. International Journal of Molecular Sciences 2023; 24(3) doi: 10.3390/ijms24032231
|
| 32 |
Mengjing Chen, Qiuju Lyu, Lina Huang, Yeliang Lou, Lingfeng Wang. Gut–brain axis and depression: focus on the amino acid and short-chain fatty acid metabolism. Behavioural Pharmacology 2025; 36(7) doi: 10.1097/FBP.0000000000000851
|
| 33 |
Amjad Mhanna, Nafiza Martini, Ghefar Hmaydoosh, George Hamwi, Mulham Jarjanazi, Ghaith Zaifah, Reem Kazzazo, Aya Haji Mohamad, Zuheir Alshehabi. The correlation between gut microbiota and both neurotransmitters and mental disorders: A narrative review. Medicine 2024; 103(5) doi: 10.1097/MD.0000000000037114
|
| 34 |
Essia Hamdi, Slah Hidouri, Marwa Kechnebbou, Salem Amara. Ascorbic acid and glutamate as therapeutics for oxidative stress and behavioral dysfunction in rats exposed to zinc nanoparticles. Toxicology and Environmental Health Sciences 2025; 17(1) doi: 10.1007/s13530-024-00246-4
|
| 35 |
Evgenii Gusev, Alexey Sarapultsev. Interplay of G-proteins and Serotonin in the Neuroimmunoinflammatory
Model of Chronic Stress and Depression: A Narrative Review. Current Pharmaceutical Design 2024; 30(3) doi: 10.2174/0113816128285578231218102020
|
| 36 |
Gauri Pathak, Aryaa Nigade, Kuttiappan Anitha, Shvetank Bhatt. Current drug targets for the treatment of depression. Brain Disorders 2025; 19 doi: 10.1016/j.dscb.2025.100270
|
| 37 |
Xiaoling Zeng, Xuan Yin, Kaiyu Cui, Wenqing Xu, Xiang Li, Wei Zhang, Wei Li, Shifen Xu. Effect of electroacupuncture on metabolic alterations in the hippocampus and dorsal raphe nucleus of Wistar Kyoto rats. Brain Research 2025; 1850 doi: 10.1016/j.brainres.2024.149409
|
| 38 |
苗佳 余. Changes in Psychological Status of Diabetic Patients after COVID-19 Infection and Its Influencing Factors. Advances in Clinical Medicine 2024; 14(05) doi: 10.12677/acm.2024.1451594
|
| 39 |
Thanasis Mitsis, Eleni Papakonstantinou, Dimitrios Vlachakis. Biological mechanisms underlying depression, epigenetics and their interplay (Review). International Journal of Epigenetics 2023; 3(1) doi: 10.3892/ije.2023.17
|
| 40 |
Muthukumaran Thulasingam, Chitra Vellapandian. Exploring New Frontiers in Pharmacological Treatment of Depression: A Review on Recent Advances. Current Medicinal Chemistry 2026; 33(6) doi: 10.2174/0109298673342524250109181220
|
| 41 |
Sofia Sakopoulos, McWelling Todman. The Effects of Psychotherapy on Single and Repeated Ketamine Infusion(s) Therapy for Treatment-Resistant Depression: The Convergence of Molecular and Psychological Treatment. International Journal of Molecular Sciences 2025; 26(14) doi: 10.3390/ijms26146673
|
| 42 |
Pietro Sarasso, Martina Billeci, Irene Ronga, Fabiola Raffone, Vassilis Martiadis, Gilberto Di Petta. Disembodiment and Affective Resonances in Esketamine Treatment of Depersonalized Depression Subtype: Two Case Studies. Psychopathology 2024; doi: 10.1159/000539714
|
| 43 |
Mario Gennaro Mazza, Mariagrazia Palladini, Sara Poletti, Francesco Benedetti. Post-COVID-19 Depressive Symptoms: Epidemiology, Pathophysiology, and Pharmacological Treatment. CNS Drugs 2022; 36(7) doi: 10.1007/s40263-022-00931-3
|
| 44 |
Anshula Mehra, Jaanvi Khanna, Gurpreet Singh, Vridhi Sachdeva, Neena Bedi. A Comprehensive Review on Major Depressive Disorder: Exploring Etiology, Pathogenesis and Clinical Approaches. Current Behavioral Neuroscience Reports 2025; 12(1) doi: 10.1007/s40473-025-00308-y
|
| 45 |
Isabela Heroiu, Gia Han Le, Maria-Christina Sioufi, Christine E. Dri, Yang Jing Zheng, Sabrina Wong, Roger S. McIntyre. Ketamine for the Treatment of Obsessive-Compulsive Disorder (OCD): A Systematic Review on Efficacy and Tolerability. Clinical Neuropharmacology 2026; doi: 10.1097/WNF.0000000000000692
|
| 46 |
Tobias Walbert, Edward K Avila, Florien W Boele, Caroline Hertler, Christine Lu-Emerson, Pim B van der Meer, Katherine B Peters, Alasdair G Rooney, Jessica W Templer, Johan A F Koekkoek. Symptom management in isocitrate dehydrogenase mutant glioma. Neuro-Oncology Practice 2025; 12(Supplement_1) doi: 10.1093/nop/npae088
|
| 47 |
Essia Hamdi, Slah Hidouri, Ana-Belén Muniz-Gonzalez, Alberto Marcos Bermejo, César Venero, Salem Amara, Ahmed Landoulsi. The role of glutamic acid-modified silica nanoparticles in promoting brain health. Advances in Redox Research 2024; 10 doi: 10.1016/j.arres.2024.100095
|
| 48 |
Olga V. Averina, Elena U. Poluektova, Yana A. Zorkina, Alexey S. Kovtun, Valery N. Danilenko. Human Gut Microbiota for Diagnosis and Treatment of Depression. International Journal of Molecular Sciences 2024; 25(11) doi: 10.3390/ijms25115782
|
| 49 |
Linsun Lin, Ziyi Guo, Zhuoyu Ren, Yanchen Feng, Peigang Fang, Tao Wang, Min Chen. Bibliometric insights into astrocytic roles in depression and treatment. Frontiers in Cellular Neuroscience 2025; 18 doi: 10.3389/fncel.2024.1521398
|
| 50 |
Mia Y. Roberts, Lisa A. Briand. Sex differences in AMPA receptor trafficking proteins. Biology of Sex Differences 2026; 17(1) doi: 10.1186/s13293-026-00849-1
|
| 51 |
Sun-Young Kim, So-Youn Woo, Hyung-Lae Kim, Yoosoo Chang, Seungho Ryu, Han-Na Kim. A shotgun metagenomic study identified short-chain fatty acid-producing species and their functions in the gut microbiome of adults with depressive symptoms: Large-scale shotgun sequencing data of the gut microbiota using a cross-sectional design. Journal of Affective Disorders 2025; 376 doi: 10.1016/j.jad.2025.01.149
|
| 52 |
Shuhao Chen, Baoyuan Zhu, Xiaodan Lu, Yuanyuan Huang, Shuhong Wang, Wei Wang, Guanchu Chen, Xuecheng Wu, Jiayi Zhou, Fengchun Wu, Kai Wu. Integrative multi-kingdom gut microbiome analysis uncovers clinical signatures of major depressive disorder. Journal of Affective Disorders 2026; 408 doi: 10.1016/j.jad.2026.121858
|
| 53 |
Teng Teng, Fang Huang, Ming Xu, Xuemei Li, Lige Zhang, Bangmin Yin, Yuping Cai, Fei Chen, Luman Zhang, Jushuang Zhang, Aoyi Geng, Chengzhi Chen, Xiaofei Yu, Jing Sui, Zheng-Jiang Zhu, Kai Guo, Chenhong Zhang, Xinyu Zhou. Microbiota alterations leading to amino acid deficiency contribute to depression in children and adolescents. Microbiome 2025; 13(1) doi: 10.1186/s40168-025-02122-w
|
| 54 |
Shu Wang, Yu-Guang Guan, Yan-Hua Zhu, Min-Zhong Wang. Role of high mobility group box protein 1 in depression: A mechanistic and therapeutic perspective. World Journal of Psychiatry 2022; 12(6): 779-786 doi: 10.5498/wjp.v12.i6.779
|
| 55 |
Jiao Li, Chao Zhang, Yao Meng, Siqi Yang, Jie Xia, Huafu Chen, Wei Liao, Laura D. Lewis. Morphometric brain organization across the human lifespan reveals increased dispersion linked to cognitive performance. PLOS Biology 2024; 22(6) doi: 10.1371/journal.pbio.3002647
|
| 56 |
Adejoke Y. Onaolapo, Olakunle J. Onaolapo. Natural Molecules in Neuroprotection and Neurotoxicity. 2024; doi: 10.1016/B978-0-443-23763-8.00026-9
|
| 57 |
Amir Saeed, Talal Alharazi, Khalid Alshaghdali, Raja Rezgui, Ibtihag Elnaem, Bunder Albdullah T. Alreshidi, Munazzah Tasleem, Mohd Saeed, Rekha Khandia. Targeting GluR3 in Depression and Alzheimer’s Disease: Novel Compounds and Therapeutic Prospects. Journal of Alzheimer's Disease 2024; 97(3) doi: 10.3233/JAD-230821
|
| 58 |
Gita Kholghi, Shirin Arjmandi-Rad, Mohammad-Reza Zarrindast, Salar Vaseghi. St. Johnʼs wort (Hypericum perforatum) and depression: what happens to the neurotransmitter systems?. Naunyn-Schmiedeberg's Archives of Pharmacology 2022; 395(6) doi: 10.1007/s00210-022-02229-z
|
| 59 |
Meijia Shan, Jingyue Zhang, Fuqin Yang, Fengchuan Cao, Yaru Yang, Wen Li, Limei Wang. Glabridin Improves Depression-Like Behaviors in Mice by Modulating Neuroinflammation via MAPK/NF-κB Signaling Pathway. Neurochemical Research 2025; 50(6) doi: 10.1007/s11064-025-04593-7
|
| 60 |
Catalina Torres Soler, Sofia H. Kanders, Mattias Rehn, Susanne Olofsdotter, Cecilia Åslund, Kent W. Nilsson. A Three-Way Interaction of Sex, PER2 rs56013859 Polymorphism, and Family Maltreatment in Depressive Symptoms in Adolescents. Genes 2023; 14(9) doi: 10.3390/genes14091723
|